Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07040163 · ClinicalTrials.gov registry record · Early Phase 1
Evaluation of Ketamine/Midazolam Sedation vs. Fentanyl/Midazolam Sedation for Image-Guided Percutaneous Procedures in Interventional Radiology
A Early Phase 1 study of Sedation and Interventional Radiology, sponsored by CAMC Health System.
- Active
- Registry status
- Early Phase 1
- Development phase
- 276
- Enrollment target
- 1
- Study location
NCT07040163: Active Early Phase 1 study of Sedation and Interventional Radiology, sponsored by CAMC Health System.
NCT07040163 is a Early Phase 1 study of Sedation and Interventional Radiology that is active but no longer recruiting, run by CAMC Health System. The registered enrollment target is 276 participants, below the 100,163-participant average among 12 other Sedation trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07040163, a Early Phase 1 study of Sedation and Interventional Radiology, is active but no longer recruiting, sponsored by CAMC Health System.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 276 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to reduce pain during interventional radiology (IR) procedures, making the experience better for patients. Typically, doctors use medications like fentanyl and midazolam for sedation. This research will focus on patients undergoing biopsies and drainage procedures, often associated with significant discomfort. Patients will be randomly assigned to receive either fentanyl/midazolam or ketamine/midazolam combinations for sedation. A coordinator will collect information on pain levels and satisfaction, as well as monitor any extra medications needed and side effects. The investigators hope to find that ketamine helps decrease pain and improves satisfaction compared to fentanyl, without increasing complications.
Primary Outcome
The patient will be asked to assess their pain based on the NRS 11-point pain score system from 0 (no pain) to 10 (worst possible pain) at three different time points: before the procedure (pre-procedure), during the procedure (intra-procedure), and after the procedure (peri-procedure). If the patient does not recall the procedure, it will be marked as a "0" for the intra-procedural portion.
Conditions Studied
Interventions
- DRUG Midazolam
- DRUG fentanyl
- DRUG ketamine
Study Locations (1)
West Virginia
- CAMC Memorial - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2025-03-07 |
| Est. Completion | 2026-06 |
| Phase | Early Phase 1 |
What the registry record for NCT07040163 still lists
NCT07040163 is an interventional study that assigns participants to a tested intervention. The registered 276 participants enrollment target is mid-sized for trials with a published cap, below the 100,163-participant average among 12 other Sedation trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with Sedation appearing as the primary indexed condition, and to 3 interventions - of which Midazolam is the first listed.
NCT07040163 reports a single indexed study location in West Virginia.
Frequently Asked Questions
What is clinical trial NCT07040163 about?
NCT07040163 is a clinical study titled "Evaluation of Ketamine/Midazolam Sedation vs. Fentanyl/Midazolam Sedation for Image-Guided Percutaneous Procedures in Interventional Radiology". This study aims to reduce pain during interventional radiology (IR) procedures, making the experience better for patients. Typically, doctors use medications like fentanyl and midazolam for sedation. This research will focus on patients undergoing biopsies and drainage procedures, often associated w...
What is the current status of trial NCT07040163?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 276 participants. The study started on 2025-03-07. Estimated completion is 2026-06.
What conditions does trial NCT07040163 study?
This clinical trial studies the following conditions: Sedation, Interventional Radiology, Biopsy, Drainage Procedure.
What interventions are being tested in trial NCT07040163?
The interventions under investigation include: Midazolam (DRUG), fentanyl (DRUG), ketamine (DRUG).
Who is sponsoring clinical trial NCT07040163?
This trial is sponsored by CAMC Health System, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07040163 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sedation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07040163's enrollment target sits among peer trials
276 5th of 12 higher than 8 of 12 other Sedation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sedation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Oral vs IV Sedation for Cataract Surgery in Older Adults
RECRUITING · Phase 4
-
Neurosteer Bedside Monitoring System
RECRUITING · NA
-
Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration
RECRUITING · Phase 3
-
The Million Anesthesia Cases Study (MACS) - a Cohort Study of Preoperative Fasting and Perioperative Outcomes
RECRUITING
-
A Pooled Analysis of Long-Term Outcomes After Inhaled Isoflurane Via the Sedaconda ACD-S Compared to Intravenous Propofol
ACTIVE NOT RECRUITING · Phase 3
-
Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU1)
ACTIVE NOT RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01371630 · 276 participants · Phase 1
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
- NCT04192344 · 276 participants · Phase 1
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
- NCT05294991 · 276 participants · NA
Wellness App for Sleep Disturbance in Hematological Cancer Patients
- NCT05610852 · 276 participants · NA
Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI